is tirzepatide better vs. Semaglutide for Weight Loss Why Tirzepatide is a better

The difference between the two dosages and the rates of NAION may indicate a dose dependent increase in risk of NAION. Benjamin Bert, MD Future research should focus on this potential dose-dependent increase in adverse events with the GLP-1 medications, Bert continued

The injectable Wegovy is widely recognized for its weekly dosage convenience, while the oral Wegovy pill serves those preferring a tablet form

Cardiovascular and Liver Fat Research Weight reduction is the headline, but the broader metabolic data from these trials matters enormously for researchers

Tirzepatide Tirzepatide, a dual GLP-1 and gastric inhibitory polypeptide receptor agonist, is TGA approved for the treatment of T2DM and obstructive sleep apnoea, and as a chronic weight management medication in adults with obesity or overweight with at least one weight-associated comorbid condition

Patients with certain GLP1R polymorphisms, for example, may achieve faster satiety if they inject consistently at the same hour each week, while others show equal benefit across variable timing

[12] [13] This elevated risk is thought to be related to shared risk factors such as obesity, insulin resistance, chronic inflammation, and metabolic dysfunction, rather than diabetes treatment itself